BMRN vs XPEV · P/E 40, rev $1.76B vs rev $895.7M
Biomarin Pharmaceutical Inc (BMRN) versus Xpeng Inc (XPEV) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Xpeng Inc (XPEV) is a auto manufacturers company listed on US. It is led by Xiaopeng He.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported XPEV revenue for 2020-12-31 was $895.7M. Net income was -$418.7M. XPEV currently screens at market cap $20.28B.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. XPEV currently screens at market cap $20.28B.
Not investment advice. Open the BMRN and XPEV stock pages for the full models.
Not investment advice.